COG’s Work in Non-Hodgkin Lymphoma

COG’s Non-Hodgkin Lymphoma Committee includes subcommittees focused on specific disease types, as well as Biology and Pathology Committees that study the mechanisms underlying pediatric lymphoma and LCH. Together, these groups develop biology studies and clinical trials aimed at advancing safer and more effective therapies for patients. Through shared expertise and continued research, this work supports improved treatment approaches and outcomes across NHL and related diseases.

Back to all Clinical Focus Areas

NHL: Key Statistics

  • > 0 %

    Survival rate for pediatric NHL in the US and Europe has increased from <20% over the last 50 years.patients.

  • 0

    New cases of pediatric NHL in the US annually.

While many children with non-Hodgkin lymphoma can be cured, treatment is often intensive, and not every subtype responds the same—driving COG researchers to develop more precise, less toxic therapies for every child.

COG Member Institutions

COG’s 220+ member institutions study and treat children and adolescents with cancer across a global network. These sites support patients from diagnosis through treatment and beyond, connecting families to clinical trials and specialized care closer to home.

Use our interactive map to find a COG member institution near you.

Find a Member Location

News from COG

As the world’s largest pediatric cancer research network, COG drives breakthroughs in treatment and improves outcomes for children with cancer. Explore the latest news and stories from across our global community.

The future for children with Non-Hodgkin lymphoma is shaped by today’s research.

Your support helps fuel discoveries that deepen understanding and move us closer to cures and more effective treatments.

Support Non-Hodgkin Lymphoma Research opens in a new tab